Schedule 13G ownership disclosure

INVO Bioscience Inc

Security class unavailable · CUSIP: 44984F104

Event date: 2019-09-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,715,942
Percent of class
7.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001185185-19-001708
Form type
SC 13G
Filer
Bowdring Robert Joseph Jr
CIK
CIK 1664410
Filed
Dec 11, 2019
Reporting period
Sep 16, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub